Understanding the response heterogeneity of different cancer cell types toward anti-mitotic drugs I-Taxol
Different types of cancer cells respond differently to anti-mitotic drug Taxol, resulting in its success and failure in its combat against cancer. Failure in the form of resistance of cancer cells to Taxol remains a huge obstacle for effective cancer treatment and for patients’ survival. In this stu...
Saved in:
Main Author: | Tan, Adeline Hui Chen |
---|---|
Other Authors: | Li Hoi Yeung |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/41761 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Understanding the response heterogeneity of different cancer cell types toward anti-mitotic drugs II – Vinblastine
by: Xiao, Li Ming
Published: (2010) -
Lipid accumulation facilitates mitotic slippage-induced adaptation to anti-mitotic drug treatment
by: Wong, Alex, et al.
Published: (2020) -
Drug resistance genotyping in HIV-I isolated from Thai patients
by: Ekachai Jenwitheesuk
Published: (2023) -
Lipid accumulation facilitates mitotic slippage-induced adaptation to anti-mitotic drug treatment
by: Wong, Alex, et al.
Published: (2023) -
Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)
by: Feng, S.-S., et al.
Published: (2014)